Studies on coagulation and fibrinolysis abnormalities in liver diseases

Coagulation-fibrinolysis abnormalities in poststroke patients.

We thank Drs Shahar, McGovern, and Spraflca for their interest in our paper in which we demonstrated, inter alia, that low doses of aspirin may not be as efficacious as higher doses. Our sample population was indeed matched, and Shahar et al are correct in pointing out that analysis for data obtained according to a matched design should have been performed. However, it is possible to ignore mat...

Coagulation-Fibrinolysis Abnormalities in Poststroke Patients

We thank Drs Shahar, McGovern, and Spraflca for their interest in our paper in which we demonstrated, inter alia, that low doses of aspirin may not be as efficacious as higher doses. Our sample population was indeed matched, and Shahar et al are correct in pointing out that analysis for data obtained according to a matched design should have been performed. However, it is possible to ignore mat...

Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy.

OBJECTIVE Familial amyloid polyneuropathy (FAP) is an autosomal dominant form of hereditary amyloidosis. Several studies reported coagulation factor X deficiency and excessive fibrinolysis in immunoglobulin light chain amyloidosis. However, few have investigated coagulation and fibrinolysis in FAP. The objective of this study was to determine abnormalities in plasma biomarkers of coagulation an...

Coagulation and Fibrinolysis Abnormalities in Patients with Muscular Dystrophy

Hemostatic abnormalities and liver diseases.

Professor Eberhard F. Mammen greatly contributed to the understanding of the relationship between hemostatic abnormalities and liver diseases. The physiology of the hemostatic system is closely linked to liver function because the liver parenchymal cells produce most of the factors of the clotting and fibrinolytic systems. Acute or chronic hepatocellular diseases and hepatic failure including l...